← Back to home

HER2 + BREAST CANCER, HER2 + GASTRIC CANCER, SQUAMOUS CELL CARCINOMA OF HEAD AND NECK, ESOPHAGEAL SQUAMOUS CELL CARCINOMA

Clinical trials for HER2 + BREAST CANCER, HER2 + GASTRIC CANCER, SQUAMOUS CELL CARCINOMA OF HEAD AND NECK, ESOPHAGEAL SQUAMOUS CELL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new HER2 + BREAST CANCER, HER2 + GASTRIC CANCER, SQUAMOUS CELL CARCINOMA OF HEAD AND NECK, ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear

Sign up with your email to follow new studies for HER2 + BREAST CANCER, HER2 + GASTRIC CANCER, SQUAMOUS CELL CARCINOMA OF HEAD AND NECK, ESOPHAGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New scan aims to see cancer more clearly during treatment

Knowledge-focused Not yet recruiting

This study is testing a new imaging tracer called [68Ga]Ga-ABY-025 to see if it can help doctors better identify and visualize tumors in patients receiving standard HER2-targeted cancer therapy. It will involve about 30 adults with advanced HER2-positive cancers who are undergoin…

Matched conditions: HER2 + BREAST CANCER, HER2 + GASTRIC CANCER, SQUAMOUS CELL CARCINOMA OF HEAD AND NECK, ESOPHAGEAL SQUAMOUS CELL CARCINOMA

Phase: EARLY_PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Knowledge-focused

Last updated Mar 24, 2026 12:01 UTC

HER2 + BREAST CANCER, HER2 + GASTRIC CANCER, SQUAMOUS CELL CARCINOMA OF HEAD AND NECK, ESOPHAGEAL SQUAMOUS CELL CARCINOMA

Get alerted when new HER2 + BREAST CANCER, HER2 + GASTRIC CANCER, SQUAMOUS CELL CARCINOMA OF HEAD AND NECK, ESOPHAGEAL SQUAMOUS CELL CARCINOMA trials appear

New scan aims to see cancer more clearly during treatment